Will MIR RTQA business return to positive organic growth in FY2026?
Current Prediction
Prediction Distribution
Individual Predictions(9 runs)
Management says transitory. Medical radiation fundamentals remain strong.
Competitive dynamics in radiation QA could indicate share loss vs cyclical softness.
Coin-flip reflecting genuine uncertainty about transitory vs structural weakness.
Management says transitory. Medical radiation fundamentals remain strong.
Competitive dynamics in radiation QA could indicate share loss vs cyclical softness.
Coin-flip reflecting genuine uncertainty about transitory vs structural weakness.
Management says transitory. Medical radiation fundamentals remain strong.
Competitive dynamics in radiation QA could indicate share loss vs cyclical softness.
Coin-flip reflecting genuine uncertainty about transitory vs structural weakness.
Resolution Criteria
Resolves YES if RTQA or relevant medical sub-segment returns to positive organic growth in FY2026. Resolves NO if flat or negative.
Resolution Source
Mirion earnings calls and quarterly filings
Source Trigger
RTQA recovery: Management calls RTQA weakness transitory -- monitor for evidence of rebound vs. structural decline.
Full multi-lens equity analysis